Evolving Clinical Strategies for Transplantation in the HIV-Positive Recipient
- 15 September 2007
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 84 (5), 563-571
- https://doi.org/10.1097/01.tp.0000279190.96029.77
Abstract
The transplant community has been slow to recognize the efficacy of highly active antiretroviral therapy in changing the course of human immunodeficiency virus (HIV) infection to a chronic condition. People infected with HIV are dying less often from progression of HIV to acquired immune deficiency syndrome. Unfortunately, there is an increasing rate of morbidity and mortality from comorbidities resulting in end-stage liver and kidney disease, prompting some transplant centers to eliminate HIV infection as a contraindication to transplantation. This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient.This publication has 52 references indexed in Scilit:
- Diverse Effects of Cyclosporine on Hepatitis C Virus Strain ReplicationJournal of Virology, 2006
- Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionJournal of Hepatology, 2006
- Guidelines for liver transplantation in patients with HIV infection (2005)HIV Medicine, 2005
- Determinants of Transplant Surgeons' Willingness to Provide Organs to Patients Infected with HBV, HCV or HIVAmerican Journal of Transplantation, 2005
- Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patientsLiver Transplantation, 2004
- Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver diseaseLiver Transplantation, 2003
- Hepatitis B and C in HIV-infected patients: Prevalence and prognostic valueJournal of Hepatology, 1997
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992
- Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseClinical Immunology and Immunopathology, 1988